Get informed when a big investor buys or sells
+ FollowOvervalued by 148.8% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $1.93 Billion |
|---|---|
| Enterprise Value | $1.82 Billion |
| Earnings per Share | $-3.7 |
| Beta | 1.47 |
| Outstanding Shares | 43,264,000 |
| P/E Ratio | -12.61 |
|---|---|
| PEG | 12.03 |
| Price to Sales | 3.26 |
| Price to Book Ratio | 1.43 |
| Enterprise Value to Revenue | 2.93 |
| Enterprise Value to EBIT | -12.74 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.07 |
No data
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 215.07% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 12.28%▼ 98.03% |
|---|---|
| Total Invested | $193.44M▼ 85.08% |
| Investors Holding | 111▼ 148.00% |
Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and oth...
Stockcircle shows 2 open-market insider purchases for Azenta in the last six months from SEC Form 4 reports by executives, directors, and other insiders.
Stockcircle lists 2 politician trade disclosures tied to Azenta in the last twelve months, drawn from periodic financial disclosure reports. 1 politician traded Azenta in the past year.
Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.